SR
SRTS.US Sensus Healthcare Inc
- Market cap
- USD 36.6M
- P/E
- -
- P/B
- 1.08x
- ROE
- -48.4%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is SRTS.US undervalued?
Graham numberThe Graham number of Sensus Healthcare Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Sensus Healthcare Inc fundamental analysis
No fundamental analysis for Sensus Healthcare Inc yet.
Sensus Healthcare Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Sensus Healthcare Inc
Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin ca…
Full company profileSensus Healthcare Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Sensus Healthcare Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 14.8M | 20.6M | 26.4M | 27.3M | 9.58M | 27.0M | 44.5M | 24.4M | 41.8M | 27.5M | 15.6M |
| Gross Profit | 9.85M | 13.8M | 16.9M | 17.6M | 5.25M | 17.0M | 29.6M | 14.1M | 24.4M | 11.9M | 6.73M |
| Operating Income | -363K | -3.72M | -2.01M | -1.97M | -8.23M | 4.12M | 14.8M | -382K | 8.09M | -10.3M | -12.2M |
| EBITDA | 13.0K | -3.25M | -1.21M | -1.15M | -6.10M | 4.73M | 28.5M | 1.11M | 9.45M | -9.00M | -11.4M |
| Net Income | -346K | -3.71M | -2.02M | -1.70M | -6.84M | 4.12M | 24.2M | 485K | 6.65M | -7.72M | -17.2M |
| EPS | -0.03 | -0.28 | -0.14 | -0.10 | -0.42 | 0.25 | 1.46 | 0.03 | 0.41 | -0.47 | -1.04 |
| Balance Sheet | |||||||||||
| Total Assets | 18.9M | 18.8M | 33.3M | 36.9M | 28.0M | 32.2M | 56.7M | 53.7M | 62.2M | 53.0M | 40.6M |
| Total Liabilities | 3.67M | 7.15M | 6.79M | 8.92M | 6.51M | 6.23M | 8.67M | 4.87M | 6.34M | 4.94M | 5.11M |
| Shareholders' Equity | 15.3M | 11.7M | 26.5M | 28.0M | 21.5M | 26.0M | 48.1M | 48.8M | 55.8M | 48.1M | 35.4M |
| Cash & Short-term Investments | 11.5M | 11.2M | 15.4M | 15.5M | 14.9M | 14.5M | 25.5M | 23.1M | 22.1M | 22.1M | 12.9M |
| Total Debt | - | 2.21M | - | 1.43M | 1.38M | 225K | 1.02M | 783K | 602K | 680K | 278K |
| Cash Flow | |||||||||||
| Operating Cash Flow | -851K | -3.06M | -8.56M | -2.11M | -434K | -286K | -1.41M | -2.15M | -831K | 528K | -12.2M |
| Capital Expenditure | 286K | 288K | 855K | 401K | 359K | 128K | 159K | 229K | 276K | 196K | 14.7K |
| Free Cash Flow | -1.14M | -3.34M | -9.42M | -2.51M | -793K | -414K | -1.57M | -2.37M | -1.11M | 332K | -12.2M |
| Ratios | |||||||||||
| ROE | -2.3% | -31.8% | -7.6% | -6.1% | -31.8% | 15.8% | 50.4% | 1.0% | 11.9% | -16.0% | -48.4% |
| ROA | -1.8% | -19.7% | -6.1% | -4.6% | -24.4% | 12.8% | 42.7% | 0.9% | 10.7% | -14.6% | -42.3% |
| Net Profit Margin | -2.3% | -18.0% | -7.7% | -6.2% | -71.4% | 15.2% | 54.4% | 2.0% | 15.9% | -28.1% | -110.2% |
| Debt to Equity | - | 0.19x | - | 0.05x | 0.06x | 0.01x | 0.02x | 0.02x | 0.01x | 0.01x | 0.01x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Sensus Healthcare Inc dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | USD 731K | 0.04 | 3.0% |
| 2021 | - | - | - |
| 2020 | USD 210K | 0.01 | - |
| 2019 | - | - | - |
| 2018 | - | - | - |
| 2017 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Sensus Healthcare Inc
- Insiders 18.67%
- Institutions 26.79%
- Public & others 54.55%
- Shares outstanding 16.5M
- Free float 13.4M
Top funds holding SRTS.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 494K | 3.00% | 0.00% | Sep 2026 |
| Adara Smaller Companies | 311K | 1.89% | 0.00% | Sep 2026 |
| M3Sixty Income and Opportunity Instl | 132K | 0.80% | -13.24% | Jun 2026 |
| North Star Micro Cap I | 126K | 0.76% | 0.00% | Sep 2026 |
| DFA U.S. Small Cap I | 75.1K | 0.46% | 0.00% | Sep 2026 |
| DFA U.S. Small Cap Value I | 73.8K | 0.45% | +63.19% | Sep 2026 |
| Fidelity Extended Market Index | 70.4K | 0.43% | -0.38% | Sep 2026 |
| iShares Micro-Cap ETF | 42.1K | 0.26% | 0.00% | Oct 2026 |
| Dimensional US Small Cap ETF | 29.1K | 0.18% | 0.00% | Oct 2026 |
| Dimensional US Small Cap Value ETF | 28.6K | 0.17% | 0.00% | Sep 2026 |
| Fidelity Total Market Index | 24.7K | 0.15% | 0.00% | Sep 2026 |
| DFA U.S. Core Equity 2 Instl | 22.5K | 0.14% | 0.00% | Sep 2026 |
| Dimensional US Core Equity 2 ETF | 21.6K | 0.13% | 0.00% | Oct 2026 |
| Fidelity Series Total Market Index | 20.9K | 0.13% | 0.00% | Sep 2026 |
| Avantis US Small Cap Equity ETF | 20.0K | 0.12% | 0.00% | Oct 2026 |
| DFA US Micro Cap I | 13.5K | 0.08% | 0.00% | Sep 2026 |
| Vanguard Balanced Index Inv | 11.6K | 0.07% | 0.00% | Sep 2026 |
| DFA U.S. Core Equity 1 I | 11.5K | 0.07% | +0.03% | Sep 2026 |
| DFA US Social Core Equity 2 Portfolio | 7.61K | 0.05% | 0.00% | Sep 2026 |
| Fidelity Nasdaq Composite Index | 7.14K | 0.04% | 0.00% | Aug 2026 |
Top institutions holding SRTS.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Pacific Ridge Capital Partners, LLC | 784K | 4.76% | -0.68% | Sep 2026 |
| Vanguard Capital Management, LLC | 660K | 4.01% | +1.88% | Jun 2026 |
| Dimensional Fund Advisors, Inc. | 301K | 1.83% | -4.76% | Sep 2026 |
| Divisadero Street Capital Management, LP | 278K | 1.69% | -2.65% | Jun 2026 |
| Renaissance Technologies Corp | 230K | 1.39% | -5.24% | Sep 2026 |
| Geode Capital Management, LLC | 154K | 0.94% | -6.88% | Jun 2026 |
| UBS Group AG | 153K | 0.93% | -11.74% | Jun 2026 |
| Sachetta LLC | 152K | 0.92% | +1.00% | Jun 2026 |
| Greenline Wealth Management LLC | 129K | 0.78% | 0.00% | Jun 2026 |
| North Star Investment Management Corp | 126K | 0.76% | 0.00% | Jun 2026 |
| Bank of New York Mellon Corp | 100K | 0.61% | 0.00% | Jun 2026 |
| MINDSET WEALTH MANAGEMENT, LLC | 86.0K | 0.52% | +65.07% | Sep 2026 |
| BlackRock Inc | 83.6K | 0.51% | +17.41% | Jun 2026 |
| Vanguard Fiduciary Trust Co | 76.3K | 0.46% | +0.74% | Jun 2026 |
| State Street Corp | 69.3K | 0.42% | 0.00% | Jun 2026 |
| Ingalls & Snyder LLC | 55.0K | 0.33% | 0.00% | Jun 2026 |
| Janney Montgomery Scott LLC | 40.6K | 0.25% | 0.00% | Jun 2026 |
| Northern Trust Corp | 28.2K | 0.17% | -58.67% | Jun 2026 |
| Chapin Davis Inc | 26.0K | 0.16% | 0.00% | Jun 2026 |
| American Century Companies Inc | 21.3K | 0.13% | 0.00% | Sep 2026 |
Sensus Healthcare Inc company profile
- Company name
- Sensus Healthcare Inc
- Ticker
- SRTS.US
- Exchange
- USA Stocks
- Listed since
- Jun 3, 2016
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 60
- Fiscal year end
- December
- Address
- 851 Broken Sound Parkway NW, Boca Raton, FL, United States, 33487
- Phone
- 561 922 5808
- Website
- sensushealthcare.com
About Sensus Healthcare Inc
Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 +; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, such as applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos, as well as provide operational healthcare services for dermatology clinics. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. The company was incorporated in 2010 and is based in Boca Raton, Florida.
Sensus Healthcare Inc management
6- Mr. Joseph C. SardanoCo-Founder, Chairman & CEO · born 1953
- Mr. Michael J. Sardano J.D.President, Chief Commercial Officer, General Counsel, Corporate Secretary & Director · born 1988
- Mr. Javier RampollaChief Financial Officer · born 1973
- Ms. Magdalena MartinezChief Operating Officer · born 1990
- Mr. Carlton ChowChief Technology Officer · born 1990
- Ms. Stephanie TiptonVice President of Marketing